N
21.60
0.08 (0.37%)
| Previous Close | 21.52 |
| Open | 21.57 |
| Volume | 204,255 |
| Avg. Volume (3M) | 297,500 |
| Market Cap | 680,951,488 |
| Price / Book | 42.81 |
| 52 Weeks Range | |
| Earnings Date | 4 Aug 2026 |
| Diluted EPS (TTM) | -1.13 |
| Current Ratio (MRQ) | 3.28 |
| Operating Cash Flow (TTM) | -12.06 M |
| Levered Free Cash Flow (TTM) | -4.67 M |
| Return on Assets (TTM) | -52.69% |
| Return on Equity (TTM) | -115.29% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Nuvectis Pharma, Inc. | Mixed | Bearish |
AIStockmoo Score
1.3
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -3.0 |
| Technical Moving Averages | 5.0 |
| Technical Oscillators | 2.0 |
| Average | 1.33 |
|
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 46.91% |
| % Held by Institutions | 9.93% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Iridian Asset Management Llc/Ct | 30 Jun 2026 | 777,078 |
| Occam Crest Management Lp | 31 Mar 2026 | 407,147 |
| Baldwin Wealth Partners Llc/Ma | 30 Jun 2026 | 382,015 |
| Forbes J M & Co Llp | 30 Jun 2026 | 59,000 |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |